Enfermedades Infecciosas
Buscador de publicaciones
Sólo se han incluido artículos originales, editoriales y revisiones.
-
Antinori A, Johnson M, Moreno S, Yazdanpanah Y, Rockstroh JK.
Report of a European Working Group on late presentation with HIV infection: recommendations and regional variation
ANTIVIRAL THERAPY . 15(1): 31-35. Nº de citas: 23
-
Ghosn J, Carosi G, Moreno S, Pokrovsky V, Lazzarin A, Pialoux G, Sanz-Moreno J, Balogh A, Vandeloise E, Biguenet S, Leleu G, Delfraissy JF.
Unboosted atazanavir-based therapy maintains control of HIV type-1 replication as effectively as a ritonavir-boosted regimen
ANTIVIRAL THERAPY . 15(7): 993-1002. Nº de citas: 33
-
Garriga C, Pérez-Elías MJ, Delgado R, Ruiz L, Pérez-Alvarez L, Pumarola T, López-Lirola A, González-García J, Menéndez-Arias L.
HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with virological failure to nucleoside drug combinations.
The Journal of antimicrobial chemotherapy . 64(2): 251-258. Nº de citas: 11
-
Pérez Cachafeiro S, Del Amo J, Iribarren JA, Salavert Lleti M, Gutiérrez F, Moreno A, Labarga P, Pineda JA, Vidal F, Berenguer J, Moreno S.
Decrease in serial prevalence of coinfection with hepatitis C virus among HIV-infected patients in Spain, 1997-2006.
CLINICAL INFECTIOUS DISEASES . 48(10): 1467-1470. Nº de citas: 52
-
Sobrino-Vegas P, García-San Miguel L, Caro-Murillo AM, Miró JM, Viciana P, Tural C, Saumoy M, Santos I, Sola J, del Amo J, Moreno S, CoRIS.
Delayed diagnosis of HIV infection in a multicenter cohort: prevalence, risk factors, response to HAART and impact on mortality.
CURRENT HIV RESEARCH . 7(2): 224-230. Nº de citas: 88
-
de Mendoza C, Anta L, García F, Pérez-Elías MJ, Gutiérrez F, Llibre JM, Menéndez-Arias L, Dalmau D, Soriano V.
HIV-1 genotypic drug resistance interpretation rules - 2009 Spanish guidelines.
AIDS REVIEWS . 11(1): 39-51. Nº de citas: 17
-
González-Nieto D, Gómez-Hernández JM, Larrosa B, Gutiérrez C, Muñoz MD, Fasciani I, O'Brien J, Zappalà A, Cicirata F, Barrio LC.
Regulation of neuronal connexin-36 channels by pH
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA . 105(44): 17169-17174. Nº de citas: 61
-
Hernández-Novoa B, Antela A, Gutiérrez C, Pérez-Molina JA, Pérez-Elías MJ, Dronda F, Moreno A, Casado JL, Page C, Pumares M, Galán JC, Moreno S.
Effect of food on the antiviral activity of didanosine enteric-coated capsules: a pilot comparative study.
HIV MEDICINE . 9(4): 187-191. Nº de citas: 5
-
Pérez-Elías MJ, Moreno A, Moreno S, López D, Antela A, Casado JL, Dronda F, Gutiérrez C, Quereda C, Navas E, Abraira V, Rodríguez MA.
Higher virological effectiveness of NNRTI-based antiretroviral regimens containing nevirapine or efavirenz compared to a triple NRTI regimen as initial therapy in HIV-1-infected adults.
HIV CLINICAL TRIALS . 6(6): 312-319. Nº de citas: 10
-
Rodes B, García F, Gutierrez C, Martinez-Picado J, Aguilera A, Saumoy M, Vallejo A, Domingo P, Dalmau D, Ribas MA, Blanco JL, Pedreira J, Perez-Elias MJ, Leal M, de Mendoza C, Soriano V.
Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.
JOURNAL OF MEDICAL VIROLOGY . 77(1): 23-28. Nº de citas: 19
-
Pérez-Elías MJ, Moreno S, Gutiérrez C, López D, Abraira V, Moreno A, Dronda F, Casado JL, Antela A, Rodríguez MA.
High virological failure rate in HIV patients after switching to a regimen with two nucleoside reverse transcriptase inhibitors plus tenofovir.
AIDS . 19(7): 695-698. Nº de citas: 21
-
Gutiérrez-Gutiérrez B, Pérez-Nadales E, Pérez-Galera S, Fernández-Ruiz M, Carratalà J, Oriol I, Cordero E, Lepe JA, Tan BH, Corbella L, Paul M, Natera AM, David MD, Montejo M, Iyer RN, Camera Pierrotti L, Merino E, Steinke SM, Rana MM, Muñoz P, Mularoni A, van Delden C, Grossi PA, Seminari EM, Gunseren F, Lease ED, Roilides E, Fortún J, Arslan H, Coussement J, Tufan ZK, Pilmis B, Rizzi M, Loeches B, Eriksson BM, Abdala E, Soldani F, Lowman W, Trindade Clemente W, Bodro M, Fariñas MC, Kazak E, Martínez-Martínez L, Aguado JM, Torre-Cisneros J, Pascual Á, Rodríguez-Baño J, Investigators from the REIPI/ESGICH/ESGBIS/INCREMENT-SOT Group.
Ertapenem for treatment of non-severe bacteremic urinary-tract infections due to ESBL-producing Enterobacterales in kidney transplant recipients: a propensity score and DOOR-based analysis.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY . : .
-
Pérez-Nadales E, Fernández-Ruiz M, Natera AM, Gutiérrez-Gutiérrez B, Mularoni A, Russelli G, Pierrotti LC, Freire MP, Falcone M, Tiseo G, Tumbarello M, Raffaelli F, Abdala E, Bodro M, Gervasi E, Fariñas MC, Seminari EM, Castón JJ, Marín-Sanz JA, Gálvez-Soto V, Rana MM, Loeches B, Martín-Dávila P, Pascual Á, Rodríguez-Baño J, Aguado JM, Martínez-Martínez L, Torre-Cisneros J.
Efficacy of ceftazidime-avibactam in solid organ transplant recipients with bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae.
AMERICAN JOURNAL OF TRANSPLANTATION . : .
-
Ros-Castelló V, Quereda C, López-Sendón J, Corral I.
Post-hypoxic myoclonus after COVID-19 infection recovery.
Movement Disorders Clinical Practice . 7(8): 983-984.
-
Albasanz-Puig A, Gudiol C, Puerta-Alcalde P, Ayaz CM, Machado M, Herrera F, Martín-Dávila P, Laporte-Amargós J, Cardozo C, Akova M, Álvarez-Uría A, Torres D, Fortún J, García-Vidal C, Muñoz P, Bergas A, Pomares H, Mercadal S, Durà-Miralles X, García-Lerma E, Pallarès N, Carratalà J.
Impact of the inclusion of an aminoglycoside to the initial empirical antibiotic therapy for Gram-negative bloodstream infections in hematological neutropenic patients: a propensity-matched cohort study (AMINOLACTAM study).
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY . : .
-
Rava M, Bisbal O, Domínguez-Domínguez L, Aleman MR, Rivero M, Antela A, Estrada V, Ribera E, Muñoz A, Iribarren JA, Moreno S, Rubio R, Jarrín I.
Late presentation for HIV impairs immunological but not virological response to antiretroviral treatment.
AIDS . : .
-
Nunez-Torron, Claudia, Ferrer-Gomez, Ana, Moreno Moreno, Esther, Perez-Mies, Belen, Villarrubia, Jesus, Chamorro, Sandra, Lopez-Jimenez, Javier, Palacios, J, Piris-Villaespesa, Miguel, Garcia-Cosio, Monica.
Secondary haemophagocytic lymphohistiocytosis in COVID-19: correlation of the autopsy findings of bone marrow haemophagocytosis with HScore
JOURNAL OF CLINICAL PATHOLOGY . : . Nº de citas: 4
-
Pierrotti LC, Pérez-Nadales E, Fernández-Ruiz M, Gutiérrez-Gutiérrez B, Hock Tan B, Carratalà J, Oriol I, Paul M, Cohen-Sinai N, López-Medrano F, San-Juan R, Montejo M, Freire MP, Cordero E, David MD, Merino E, Mehta Steinke S, Grossi PA, Cano Á, Seminari EM, Valerio M, Gunseren F, Rana M, Mularoni A, Martín-Dávila P, van Delden C, Hamiyet Demirkaya M, Koçak Tufan Z, Loeches B, Iyer RN, Soldani F, Eriksson BM, Pilmis B, Rizzi M, Coussement J, Clemente WT, Roilides E, Pascual Á, Martínez-Martínez L, Rodríguez-Baño J, Torre-Cisneros J, María Aguado J, Investigators from the REIPI/INCREMENT-SOT Group.
Efficacy of ß-lactam/ß-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project).
TRANSPLANT INFECTIOUS DISEASE . : .